Biological therapies in systemic lupus erythematosus
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2012, Vol 66, Issue 0
Abstract
The prevention of chronic organic damage and complete inhibition of inflammatory activity of the disease are the main goals in the treatment of systemic lupus erythematosus (SLE). Current therapies of SLE are not effective enough and they may cause various serious side effects. Biological therapies, affecting important pathogenetic disturbances in the immunological system of SLE patients, give hope for the development of a new treatment for SLE. Currently the most advanced clinical trials are being conducted with anti-lymphocyte B drugs, such as rituximab, belimumab and epratuzumab. Belimumab as the first biological agent was registered for treatment of the active, seropositive form of SLE. The advances in immunology and rheumatology nowadays raise the hope of finding effective and safe treatment for SLE. In our article we present an overview of data concerning perspectives of biological treatment in SLE.
Authors and Affiliations
Dorota Suszek, Radosław Jeleniewicz, Maria Majdan
Keywords
Related Articles
- EP ID EP66751
- DOI -
- Views 134
- Downloads 0
Role of ghrelin and leptin in the regulation of carbohydrate metabolism. Part I. Ghrelin
Ghrelin is a polypeptide that is excreted by the secretory cells of the gastric and intestinal mucosa, the arcuate nucleus of the hypothalamus as well as by the epsilon cells (ε) located in the pancreatic islets. It play...
Rola białka AS160/TBC1D4 w transporcie glukozy do wnętrza miocytów[i][/i]
Mięśnie szkieletowe to jedne z najważniejszych tkanek uczestniczących w utrzymaniu homeostazy glukozy całego organizmu. Glukoza przenika do komórek mięśniowych na zasadzie dyfuzji ułatwionej, zachodzącej z udziałem tra...
Interactions of proliferation and differentiation signaling pathways in myogenesis
The commitment of myogenic cells in skeletal muscle differentiation requires earlier irreversible interruption of the cell cycle. At the molecular level, several key regulators of the cell cycle have been identified: cyc...
Mobile antibiotic resistance – the spread of genes determining the resistance of bacteria through food products
In recent years, more and more antibiotics have become ineffective in the treatment of bacterial nfections. The acquisition of antibiotic resistance by bacteria is associated with circulation of genes in the environment....
Well-known and new variants of pathogenic Escherichia coli as a consequence of the plastic genome
E. coli is a diverse bacterial species encompassing commensal as well as intestinal and extraintestinal pathogenic strains. The ability to adapt to so many different niches in the host organism is determined by the extre...